The intestinal microbiota and obesity
- PMID: 22064556
- DOI: 10.1097/MCG.0b013e31823711fd
The intestinal microbiota and obesity
Abstract
Obesity has been and continues to be an epidemic in the United States. Obesity has been addressed in multiple health initiatives, including Healthy People 2010, with no state meeting the proposed goal of a prevalence of obesity < 15% of the adult population. In contrast, obesity rates have continued to increase, with the self-reported prevalence of obesity among adults increasing by 1.1% from 2007 to the present. Indeed, since 2009, 33 states reported obesity prevalences of 25% or more with only 1 state reporting prevalence < 20%. There have been multiple approaches for the treatment of obesity, including fad diets, incentive-based exercise programs, and gastric bypass surgery; none of which have been optimal. In a murine model, it was shown that the majority of the intestinal microbiome consists of two bacterial phyla, the Bacteroidetes and the Firmicutes, and that the relative abundance of these two phyla differs among lean and obese mice; the obese mouse had a higher proportion of Firmicutes to Bacteroidetes (50% greater) than the lean mouse. The same results were appreciated in obese humans compared to lean subjects. The postulated explanation for this finding is that Firmicutes produce more complete metabolism of a given energy source than do Bacteroidetes, thus promoting more efficient absorption of calories and subsequent weight gain. Researchers were able to demonstrate that colonizing germ-free mice with the intestinal microbiome from obese mice led to an increased total body fat in the recipient mice despite a lack of change in diet. The converse, that, colonizing germ-free obese mice with the intestinal microbiome of thin mice causing a decreased total body fat in the recipient mice, has not yet been done. Other possible mechanisms by which the intestinal microbiome affects host obesity include induction of low-grade inflammation with lipopolysaccharide, regulation of host genes responsible for energy expenditure and storage, and hormonal communication between the intestinal microbiome and the host. The following review discusses the microbiome-obesity relationship and proposed mechanisms by which the intestinal microbiota is hypothesized to influence weight gain.
Similar articles
-
Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.Gut. 2013 Feb;62(2):220-6. doi: 10.1136/gutjnl-2011-300705. Epub 2012 Feb 16. Gut. 2013. PMID: 22345653
-
Gut carbohydrate metabolism instead of fat metabolism regulated by gut microbes mediates high-fat diet-induced obesity.Benef Microbes. 2014 Sep;5(3):335-44. doi: 10.3920/BM2013.0071. Benef Microbes. 2014. PMID: 24675232
-
Obesity, metabolic syndrome, and microbiota: multiple interactions.J Clin Gastroenterol. 2010 Sep;44 Suppl 1:S16-8. doi: 10.1097/MCG.0b013e3181dd8b64. J Clin Gastroenterol. 2010. PMID: 20535027
-
Intestinal microbiota in inflammation and insulin resistance: relevance to humans.Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):334-40. doi: 10.1097/MCO.0b013e328347924a. Curr Opin Clin Nutr Metab Care. 2011. PMID: 21587065 Review.
-
[The association of intestinal microbiota with obesity].Rev Med Chil. 2010 Aug;138(8):1020-7. Epub 2010 Nov 26. Rev Med Chil. 2010. PMID: 21140062 Review. Spanish.
Cited by
-
The human gut microbiome and body metabolism: implications for obesity and diabetes.Clin Chem. 2013 Apr;59(4):617-28. doi: 10.1373/clinchem.2012.187617. Epub 2013 Feb 11. Clin Chem. 2013. PMID: 23401286 Free PMC article. Review.
-
Gut microbiota and meat quality.Front Microbiol. 2022 Aug 23;13:951726. doi: 10.3389/fmicb.2022.951726. eCollection 2022. Front Microbiol. 2022. PMID: 36081790 Free PMC article. Review.
-
Administration of Metabiotics Extracted From Probiotic Lactobacillus rhamnosus MD 14 Inhibit Experimental Colorectal Carcinogenesis by Targeting Wnt/β-Catenin Pathway.Front Oncol. 2020 Jun 2;10:746. doi: 10.3389/fonc.2020.00746. eCollection 2020. Front Oncol. 2020. PMID: 32670864 Free PMC article.
-
Effects of Initial Combinations of Gemigliptin Plus Metformin Compared with Glimepiride Plus Metformin on Gut Microbiota and Glucose Regulation in Obese Patients with Type 2 Diabetes: The INTESTINE Study.Nutrients. 2023 Jan 3;15(1):248. doi: 10.3390/nu15010248. Nutrients. 2023. PMID: 36615904 Free PMC article. Clinical Trial.
-
Activation of natural killer T cells contributes to triptolide-induced liver injury in mice.Acta Pharmacol Sin. 2018 Dec;39(12):1847-1854. doi: 10.1038/s41401-018-0084-9. Epub 2018 Jul 16. Acta Pharmacol Sin. 2018. PMID: 30013034 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical